Home > Insider Trading > Vertex Pharmaceuticals Inc / Ma

Vertex Pharmaceuticals Inc / Ma (VRTX)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
31 - 40
Next >>

What Gives Vertex Pharmaceuticals Incorporated (VRTX) a Significant Competitive Advantage?

Harding Loevner, an asset management company, released its “Global Equity Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.

Keep Reading →

February 9th, 2024 - Hedge Fund Investor Letters News

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2023 Earnings Call Transcript

Operator: Good day, and welcome to the Vertex Pharmaceuticals Fourth Quarter 2023 Earnings Call. All participants will be in a listen-only mode.

Keep Reading →

February 6th, 2024 - News Transcripts

12 S&P 500 Stocks On the Move

The United States economy has continued to defy expectations of a macro slowdown over the past few months and looks set to grow at a healthy pace in the first quarter of 2024.

Keep Reading →

January 22nd, 2024 - Hedge Funds News

5 Most Promising Gene Editing Stocks According to Hedge Funds

In this piece, we will take a look at the five most promising gene editing stocks according to hedge funds.

Keep Reading →

December 20th, 2023 - Hedge Funds News

30 Largest Pharmaceutical Companies in the World

In this article, we will be taking a look at the 30 largest pharmaceutical companies in the world.

Keep Reading →

December 12th, 2023 - Industries Lists News

Jim Simons Stock Portfolio: 10 Top Stock Picks

In June this year, Stony Brook University, a public college in New York, saw the endowment fund it had swell from $370 million to more than $1 billion overnight, thanks in large part to a $500 million...

Keep Reading →

December 8th, 2023 - Hedge Funds News

5 Best Debt Free Stocks To Buy

Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.

Keep Reading →

November 16th, 2023 - Hedge Funds News

Jim Simons Stock Portfolio: 5 Biggest Healthcare Stocks

In this piece, we will take a look at the five biggest healthcare stocks in Jim Simons' stock portfolio.

Keep Reading →

November 13th, 2023 - Hedge Funds News

12 Best Low Beta Stocks To Buy

In this piece, we will take a look at the 12 best low beta stocks to buy.

Keep Reading →

November 13th, 2023 - Hedge Funds News

Top 20 Drug Companies in the US by Revenue

Following the Covid-19 pandemic, which drastically altered the way of living, the top pharmaceutical or drug companies in the world became the center of attention for people everywhere due to the spike...

Keep Reading →

November 9th, 2023 - Industries Lists News